GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Virax Biolabs Group Ltd (NAS:VRAX) » Definitions » 5-Year Yield-on-Cost %

VRAX (Virax Biolabs Group) 5-Year Yield-on-Cost % : 0.00 (As of Apr. 15, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Virax Biolabs Group 5-Year Yield-on-Cost %?

Virax Biolabs Group's yield on cost for the quarter that ended in Sep. 2024 was 0.00.


The historical rank and industry rank for Virax Biolabs Group's 5-Year Yield-on-Cost % or its related term are showing as below:



VRAX's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.67
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Virax Biolabs Group's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Virax Biolabs Group's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Virax Biolabs Group's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Virax Biolabs Group's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Virax Biolabs Group's 5-Year Yield-on-Cost % falls into.


;
;

Virax Biolabs Group 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Virax Biolabs Group is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Virax Biolabs Group  (NAS:VRAX) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Virax Biolabs Group 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Virax Biolabs Group's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Virax Biolabs Group Business Description

Traded in Other Exchanges
N/A
Address
Bo’Ness Road Newhouse, BioCity Glasgow, London, GBR, ML1 5UH
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.